We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Fresenius Medical Care
FMS
$13.4B
| $1.1M | ﹤0.01% |
38,564
-17,427
| -31% | -$468K |
|
2527
Vitamin Cottage Natural Grocers
NGVC
$729M
| $1.1M | ﹤0.01% |
27,934
-2,719
| -9% | -$126K |
|
2528
OptimizeRx
OPRX
$120M
| $1.09M | ﹤0.01% |
80,973
+28,410
| +54% | +$311K |
|
2529
Kura Sushi USA
KRUS
$570M
| $1.09M | ﹤0.01% |
12,688
-2,885
| -19% | -$189K |
|
2530
OraSure Technologies
OSUR
$273M
| $1.09M | ﹤0.01% |
364,038
+165,123
| +83% | +$476K |
|
|
NLOP
2531
Net Lease Office Properties
NLOP
$171M
| $1.09M | ﹤0.01% |
33,417
-6,631
| -17% | -$203K |
|
|
CTO
2532
CTO Realty Growth
CTO
$744M
| $1.08M | ﹤0.01% |
62,849
-74,176
| -54% | -$1.34M |
|
|
MHI
2533
DELISTED
Pioneer Municipal High Income Fund
MHI
| $1.08M | ﹤0.01% |
118,279
| – | – |
|
2534
Ribbon Communications
RBBN
$359M
| $1.08M | ﹤0.01% |
269,521
-61,273
| -19% | -$221K |
|
2535
Taysha Gene Therapies
TSHA
$1.59B
| $1.07M | ﹤0.01% |
465,144
-81,270
| -15% | -$177K |
|
2536
Columbia Financial
CLBK
$1.13B
| $1.07M | ﹤0.01% |
73,772
-17,061
| -19% | -$243K |
|
2537
EyePoint Inc
EYPT
$1.04B
| $1.07M | ﹤0.01% |
113,730
-81,167
| -42% | -$561K |
|
2538
ARKO Corp
ARKO
$897M
| $1.07M | ﹤0.01% |
252,924
-72,026
| -22% | -$315K |
|
2539
Manitowoc
MTW
$523M
| $1.07M | ﹤0.01% |
88,805
-10,210
| -10% | -$100K |
|
|
MTSR
2540
DELISTED
Metsera Inc
MTSR
| $1.07M | ﹤0.01% |
37,462
+17,145
| +84% | +$426K |
|
|
SMLR
2541
DELISTED
Semler Scientific
SMLR
| $1.06M | ﹤0.01% |
27,260
-91
| -0.3% | -$3.24K |
|
2542
Phathom Pharmaceuticals
PHAT
$953M
| $1.06M | ﹤0.01% |
110,110
+8,590
| +8% | +$47.5K |
|
2543
Allient
ALNT
$1.47B
| $1.06M | ﹤0.01% |
29,060
-2,110,401
| -99% | -$58.7M |
|
2544
Hingham Institution for Saving
HIFS
$613M
| $1.05M | ﹤0.01% |
4,246
-997
| -19% | -$241K |
|
2545
Xencor
XNCR
$1.47B
| $1.05M | ﹤0.01% |
134,051
-27,098
| -17% | -$243K |
|
2546
Arvinas
ARVN
$530M
| $1.05M | ﹤0.01% |
142,782
-23,815
| -14% | -$175K |
|
2547
Mineralys Therapeutics
MLYS
$2.4B
| $1.05M | ﹤0.01% |
77,647
+9,770
| +14% | +$142K |
|
2548
South Plains Financial
SPFI
$838M
| $1.05M | ﹤0.01% |
29,138
-25,469
| -47% | -$876K |
|
2549
NerdWallet
NRDS
$613M
| $1.05M | ﹤0.01% |
95,447
-309,031
| -76% | -$3.1M |
|
2550
CEVA Inc
CEVA
$980M
| $1.04M | ﹤0.01% |
47,534
-15,710
| -25% | -$349K |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.